Viewing StudyNCT05840289



Ignite Creation Date: 2024-05-06 @ 6:57 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05840289
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-05-06
First Post: 2023-04-21

Brief Title: A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma
Sponsor: University Hospital Geneva
Organization: University Hospital Geneva

Conditions & Keywords Data

Conditions:
Name
Aggressive B-Cell Non-Hodgkin Lymphoma
Keywords:
Name View
prevention View
Aggressive B-cell non-Hodgkin lymphoma View
tumor lysis syndrome View
fractionated rituximab View